ALCAM and urinary bladder carcinoma: It has also been shown that ALCAM, together with a few other cell cycle and drug markers, are key markers in resistance colorectal cancer cells (HCT116 and HT29) to chemotherapy drugs [154] and can also be altered in response to capsaicin in bladder cancer cells [155].